Dr. Patrick Medina is a pharmacist who is specialized in Oncology in Oklahoma City, Oklahoma. Patients can reach him at 800 Ne 10th St, Oklahoma City or contact him on 405-271-4022. Active license number of Dr. Patrick Medina is 12641 for Oncology in Oklahoma. Dr. Patrick Medina is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Patrick Medina speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Patrick Medina
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Male
Location:
800 Ne 10th St, Oklahoma City, Oklahoma, 73104-5418
Phone:
405-271-4022
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Patrick Medina are as mentioned below.
NPI Number:
1699123711
NPI Enumeration Date:
31 May, 2016
NPI Last Update On:
31 May, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Patrick Medina are as mentioned below.
Specialization
License Number
State
Status
Oncology
12641
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
800 Ne 10th St, Oklahoma City, Oklahoma
Zip:
73104-5418
Phone Number:
405-271-4022
Fax Number:
--
Patients can reach Dr. Patrick Medina at 800 Ne 10th St, Oklahoma City, Oklahoma or can call on phone at 405-271-4022.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.